KRMD Similar Chart Price Prediction
The price of KRMD is predicted to go up -57.65%, based on the high correlation periods with NINE. The similarity of these two price pattern on the periods is 98.51%.
KRMD
NINE
Down: -57.65%Similarity: 98.51%
KRMD Revenue Forecast
KRMD EPS Forecast
KRMD FAQs
What is KRMD revenue forecast for next quarter？
What is KRMD eps forecast for next quarter？
KRMD Analyst's Forecast
Jason Bednar
Piper Sandler
Buy → Hold
2025-02-14
Price Target
$4.5
Upside
+2.97%
Piper Sandler analyst Jason Bednar downgraded Koru Medical to Neutral from Overweight with an unchanged price target of $4.50. The company's execution "has unquestionably improved," but the stock's valuation is sitting near multi-year highs even off potentially higher revenue numbers, the analyst tells investors in a research note. The firm says Koru's "loftier valuation" is making it "slightly more uneasy about other items," including tougher compares for the U.S. subcutaneous immunoglobulin market, its limited gross margin upside in 2025 and 2026 due to geographic mix, and novel therapies revenue catalysts that look more weighted to 2026 and beyond. As such, Piper believes other stocks offer a superior risk/reward.
Frank Takkinen
Lake Street
Strong Buy
2025-01-14
Price Target
$4 → $5
Upside
+22.85%
Chase Knickerbocker
Craig-Hallum
Strong Buy
2024-11-14
Price Target
$4 → $5
Upside
+62.34%
